 |
Product Name: |
PREDNISOLONE CAS 5060-55-9 |
Company Catalog: |
|
CAS No.: |
5060-55-9 |
Specifications: |
BP/USP/EP |
Packaging: |
1.0kgs/Al- Bottle 2.0kgs/Al- Bottle 5.0 kgs/Al-Bottle 25.0 kgs/drum |
|
Product Description: |
|
Chemical products 50-24-8,Prednisolone
Product Description
Product Name
|
Prednisolone
|
Synonyms
|
DEHYDROHYDROCORTISONE;HYDRODELTALONE;METACORT AND RALONE; METACORTANDROLONE; 11B,17,21-TRIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE;11BETA,17ALPHA,21-TRIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE;11BETA 17,21-TRIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE;11-BETA,17-ALPHA,21-HYDROXY-1,4-PREGNADIENE-3,20-DIONE
|
CAS
|
50-24-8
|
EINECS
|
200-021-7
|
Molecular formula
|
C21H28O5
|
Molecular Weight
|
360.44
|
Molecular Structure
|
|
Physical and Chemical Properties
|
M.P.
|
240 °C (dec.)(lit.)
|
B.P.
|
570.6±50.0 °C at 760 mmHg
|
Density
|
1.3±0.1 g/cm3
|
F.P.
|
313.0±26.6 °C
|
Refractive index
|
1.612
|
Storage Temperature
|
-20°C Freezer
|
|
General Description
|
A white or almost white crystalline powder
|
Usage
|
Prednisolone is used for the treatment of a wide range of inflammatory and auto-immune conditions such as asthma,uveitis, pyoderma gangrenosum, rheumatoid arthritis, ulcerative colitis, temporal arteritis and Crohn's disease, Bell's palsy, multiple sclerosis cluster headaches, vasculitis, acute lymphoblastic leukemia and autoimmune hepatitis, systemic lupus erythematosus, and dermatomyositis. It is also used for treatment of sarcoidosis, though
|
Packing
|
25kg/drum
|
Storage condition
|
Store in an airtight container, protected from light.
|
Specifications
|
Items
|
Standard
|
Appearance
|
A white or almost white crystalline powder
|
Identification
|
IR absorption meets specification
|
TLC test meets specification
|
Loss on drying
|
≤1.0%
|
Related substances
|
Any individual impurity:≤1.0%
|
≥0.5% impurity:≤1
|
Total impurities:≤2.0%
|
Assay (on dried basis)
|
97.0% ~103.0%
|
Organic volatile impurities
|
methanol≤3000ppm
|
Dichloromethane≤600ppm
|
|
|